Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
39000
Units (Sixth Series Stock Acquisition Rights)Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Designation of the Fifth Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the Sixth Series Stock Acquisition Rights for suspension of exercise, and acquisition and cancellation of the Sixth Series Stock Acquisition Rights
発行・処分する株式数
Fifth Series Stock Acquisition Rights: 35,741 units not exercised (3,574,100 shares); Sixth Series Stock Acquisition Rights: 39,000 units (3,900,000 shares)
Intended allottee
Cantor Fitzgerald Europe
Total issue value
Sixth Series Stock Acquisition Rights: ¥936,000 (¥24 per stock acquisition right)
Amount of funds to be raised
Cumulative amount paid in through the exercise of the Fifth Series Stock Acquisition Rights: ¥837,341,640; estimated net proceeds: Not disclosed
Specific use of funds
Repayment of Borrowings
Marketing expenses for the traditional Japanese clothing business
Store development expenses aimed at acquiring new customers
Terms of the stock acquisition rights
Exercise price
Fifth Series Stock Acquisition Rights: with an exercise price adjustment clause (initial exercise price and adjustment floor: Not disclosed); Sixth Series Stock Acquisition Rights: Not disclosed
Exercise period
Fifth Series Stock Acquisition Rights: designated for suspension of exercise from 26 March 2026 through 29 August 2028; Sixth Series Stock Acquisition Rights: designated for suspension of exercise from 26 March 2026 through 20 April 2026
Number of Stock Acquisition Rights
Total issued: 39,000 Sixth Series Stock Acquisition Rights; remaining unexercised: 35,741 Fifth Series Stock Acquisition Rights and 39,000 Sixth Series Stock Acquisition Rights (0 Sixth Series Stock Acquisition Rights after acquisition and cancellation on 20 April 2026)
Reason for acquisition without consideration
All remaining Sixth Series Stock Acquisition Rights will be acquired and cancelled in accordance with the provisions of the terms and conditions of the Sixth Series Stock Acquisition Rights.
Most recent equity financing
Timing 29 August 2025 / Type Issuance by way of a third-party allotment of the Fifth Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the Sixth Series Stock Acquisition Rights / Amount Not disclosed
Impact on Business Performance
The acquisition and cancellation of the Sixth Series Stock Acquisition Rights will have no impact on the Company's performance for the current fiscal year.
| Item | Details |
|---|---|
| Type of issuance or disposal | Designation of the Fifth Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the Sixth Series Stock Acquisition Rights for suspension of exercise, and acquisition and cancellation of the Sixth Series Stock Acquisition Rights |
| Number of shares to be issued or disposed of | Fifth Series Stock Acquisition Rights: 35,741 units not exercised (3,574,100 shares); Sixth Series Stock Acquisition Rights: 39,000 units (3,900,000 shares) |
| Total issue value | Sixth Series Stock Acquisition Rights: ¥936,000 (¥24 per stock acquisition right) |
| Amount of funds to be raised | Cumulative amount paid in through the exercise of the Fifth Series Stock Acquisition Rights: ¥837,341,640; estimated net proceeds: Not disclosed |
| Specific use of funds | Details Repayment of Borrowings / Amount Not disclosed / Scheduled timing of expenditures Not disclosed, Details Marketing expenses for the traditional Japanese clothing business / Amount Not disclosed / Scheduled timing of expenditures Not disclosed, Details Store development expenses aimed at acquiring new customers / Amount Not disclosed / Scheduled timing of expenditures Not disclosed |
| Intended allottee | Cantor Fitzgerald Europe |
| Exercise price | Fifth Series Stock Acquisition Rights: with an exercise price adjustment clause (initial exercise price and adjustment floor: Not disclosed); Sixth Series Stock Acquisition Rights: Not disclosed |
| Exercise period | Fifth Series Stock Acquisition Rights: designated for suspension of exercise from 26 March 2026 through 29 August 2028; Sixth Series Stock Acquisition Rights: designated for suspension of exercise from 26 March 2026 through 20 April 2026 |
| Number of Stock Acquisition Rights | Total issued: 39,000 Sixth Series Stock Acquisition Rights; remaining unexercised: 35,741 Fifth Series Stock Acquisition Rights and 39,000 Sixth Series Stock Acquisition Rights (0 Sixth Series Stock Acquisition Rights after acquisition and cancellation on 20 April 2026) |
| Reason for acquisition without consideration | All remaining Sixth Series Stock Acquisition Rights will be acquired and cancelled in accordance with the provisions of the terms and conditions of the Sixth Series Stock Acquisition Rights. |
| Most recent equity financing | Timing 29 August 2025 / Type Issuance by way of a third-party allotment of the Fifth Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the Sixth Series Stock Acquisition Rights / Amount Not disclosed |
| Impact on Business Performance | The acquisition and cancellation of the Sixth Series Stock Acquisition Rights will have no impact on the Company's performance for the current fiscal year. |
Items this document does not state (16)
Issue price and disposal priceEstimated issuance expensesPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Business performance for the fiscal year ending March 2026 has remained strong, and profit is expected to exceed the initial plan. As the Company has made progress in securing the funds originally planned and strengthening its financial base, and after comprehensively considering its future financial balance, the need to limit dilution, and its capital policy, it determined that it would be appropriate to acquire and cancel the Sixth Series Stock Acquisition Rights and address the Fifth Series Stock Acquisition Rights through suspension of exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.